Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Ryanair Holdings plc — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.69 (market cap $25.27B), while Ryanair Holdings plc trades at $53.03 (market cap $27.11B). The key difference: Royalty Pharma plc Class A Ordinary Shares and Ryanair Holdings plc are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares is trading nearer its 52-week high, Ryanair Holdings plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Ryanair Holdings plc for 72 Days on average.
| RPRX | RYAAY | |
|---|---|---|
Market Cap | $25.27B | $27.11B |
Volume | 3,671,183 | 2,427,380 |
Sector | Health | Industrials |
52-Week High | $63.96 | $73.82 |
52-Week Low | $35.44 | $51.95 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $32.50B | $24.18B |
Dividend Yield | 1.66% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RYAAY trades at $53.1, down 5.18% on the day, reflecting a bearish technical signal amid mixed earnings performance. The company maintains strong profitability with a 12.13% net income margin and 22.41% ROE, while valuation metrics like a P/E of 13.43 appear attractive. Recent news highlights CEO commentary on Boeing MAX 10 certification delays and concerns over rising fuel costs impacting future airfares.
The stock presents a value opportunity given its low valuation multiples and robust cash flow generation, but faces near-term headwinds from volatile fuel prices and a lowered FY27 traffic outlook. Analyst consensus remains moderately bullish, though technical indicators suggest caution. Key risks include oil price sensitivity and competitive pressures in the European airline sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
